DBDren Bio$350M · Undisclosed · San Carlos, USA · Biotech & Pharma
What changedRaised $350M, led by Juvia Group and Lightspeed Venture Partners.
The company said the funding supports support its clinical development, regulatory submission, and planned commercial launch of its lead investigational therapy, dibotatug (DR-01), expand it into additional indications, and accelerate the development of its broader pipeline across oncology, immunology, and neurology.
Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringLicensing and BD partnershipsMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified